Home / Pharmaceutical company intelligence
Nabiqasim Industries (Pvt) Ltd., logo
Pharmaceutical company intelligence

Nabiqasim Industries (Pvt) Ltd.,

Private pharmaceutical manufacturer · Karachi · Pakistan

Pakistan-based pharmaceutical manufacturer producing branded generic formulations with domestic and international operations.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗ LinkedIn ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date4 Aug 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Nabiqasim Industries (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
5th Floor, Commerce Centre, Hasrat Mohani Road, Karachi, Pakistan
Phone
+92 21 111 742 762
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000105 Nabi Qasim Industries (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000105 368 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx365public portfolio records represented
REG272unique registrations represented
IDX365indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR365current validated price records
G118generic molecules in indexed catalogue
DF15dosage-form groups
TA16therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage100%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage92%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixNabiqasim Industries (Pvt) Ltd.,Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nabiqasim-industries-pvt-ltdGenerated 24 Sep 2026Anti-infectives135 · 37%CNS & mental health55 · 15%Cardiovascular51 · 14%Endocrine & metabolic40 · 11%Hematology & thrombosis20 · 5%Gastrointestinal & hepatology20 · 5%Respiratory & allergy10 · 3%Other therapeutic areas34 · 9%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioNabiqasim Industries (Pvt) Ltd.,Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nabiqasim-industries-pvt-ltdGenerated 24 Sep 2026365presentationsTablet224 · 61%Injection40 · 11%Capsule29 · 8%Suspension19 · 5%Cream17 · 5%Sachet9 · 2%Other forms27 · 7%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionNabiqasim Industries (Pvt) Ltd.,Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nabiqasim-industries-pvt-ltdGenerated 24 Sep 2026335comparable productsBelow peer median63 · 19%Near peer median112 · 33%Above peer median160 · 48%Company median price position+4.4%Lowest-price equivalents33Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsNabiqasim Industries (Pvt) Ltd.,Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nabiqasim-industries-pvt-ltdGenerated 24 Sep 2026Bio-Labs(Pvt) Ltd53 shared45% overlapAtco Laboratories Limited50 shared42% overlapM/s. Genix Pharma (Pvt) Ltd.49 shared42% overlapCCL Pharmaceuticals (Pvt.) Limited49 shared42% overlapMacter International Limited48 shared41% overlapMediate Pharmaceutical Pvt Ltd48 shared41% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives135 products · 37%
CNS & mental health55 products · 15%
Cardiovascular51 products · 14%
Endocrine & metabolic40 products · 11%
Hematology & thrombosis20 products · 5%
Gastrointestinal & hepatology20 products · 5%
Respiratory & allergy10 products · 3%
Vitamins, minerals & nutrition9 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antidiabetic medicines39 products · 11%
Antifungals32 products · 9%
Antivirals29 products · 8%
Antipsychotics29 products · 8%
Lipid-lowering medicines16 products · 4%
Macrolide antibacterials16 products · 4%
Third-generation cephalosporins13 products · 4%
Antiepileptics13 products · 4%
Formulation footprint

Dosage forms

Tablet224 products
Injection40 products
Capsule29 products
Suspension19 products
Cream17 products
Sachet9 products
Syrup8 products
Gel5 products
Ointment4 products
Solution3 products
Infusion2 products
Pessary2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 Glempa-MEmpagliflozin + Metformin 12presentations 12.5 mg + 1000 mg, 12.5 mg + 500 mg, 12.5 mg + 850 mg, 5 mg + 1000 mg · Tablet #2 Am-DescolAmlodipine + Atorvastatin 10presentations 10 mg + 10 mg, 10 mg + 20 mg, 10 mg + 40 mg, 5 mg + 10 mg · Tablet #3 NixvomOndansetron 9presentations 4 mg, 4 mg/2 mL, 8 mg, 8 mg/4 mL · Tablet, Injection #4 XarivaRivaroxaban 9presentations 10 mg, 15 mg, 2.5 mg, 20 mg · Tablet #5 ClarithroClarithromycin 8presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet, Injection #6 HypovirAciclovir 8presentations 200 mg, 200 MG/5 mL, 250 mg, 400 mg · Tablet, Suspension, Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median6319% of comparable products
Near market median112within ±5% of median
Above market median16048% of comparable products
Lowest-price equivalents33ties included
Company median price position +4.4% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Predsol Oph. Susp 10 mg/mLPrednisolone · Suspension · 15ml PKR 5.42/mL-79.8% vs market median Silderm 10 mg/gSilver sulfadiazine · Cream · 250g PKR 1.94/g-62.5% vs market median Normitab-25 25 mgAtenolol · Tablet · 14's PKR 3.65/tablet-35.2% vs market median Livent 1 mgEntecavir · Tablet · 30s PKR 386.65/tablet-34.8% vs market median Livent 0.5 mgEntecavir · Tablet · 30s PKR 232.01/tablet-34.8% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Bio-Labs(Pvt) Ltd236 products · 82 generics 53shared generics Atco Laboratories Limited278 products · 94 generics 50shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 49shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 49shared generics Macter International Limited256 products · 93 generics 48shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 48shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers272Distinct registrations among indexed, published, presentation-validated products only
Verified price observations368
Products with a verified price365
Products with multiple price observations3
Source records with multiple versions361
Latest portfolio source check22 Sep 2026
Latest effective price date4 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

272 unique registration(s) · 365 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Am-Descol Amlodipine + Atorvastatin 5 mg + 10 mg Tablet 7's 045339 PKR 528.42 PKR 75.49/tablet 81% above median
Am-Descol Amlodipine + Atorvastatin 5 mg + 20 mg Tablet 7's 045340 PKR 835.38 PKR 119.34/tablet 130% above median
Am-Descol Amlodipine + Atorvastatin 5 mg + 40 mg Tablet 14's 047162 PKR 1,212.51 PKR 86.61/tablet Near median
Am-Descol Amlodipine + Atorvastatin 5 mg + 40 mg Tablet 10's 047162 PKR 866.08 PKR 86.61/tablet Near median
Am-Descol Amlodipine + Atorvastatin 10 mg + 10 mg Tablet 14's 047163 PKR 581.04 PKR 41.50/tablet 98% above median
Am-Descol Amlodipine + Atorvastatin 10 mg + 10 mg Tablet 10's 047163 PKR 416.60 PKR 41.66/tablet 99% above median
Am-Descol Amlodipine + Atorvastatin 10 mg + 20 mg Tablet 14's 047164 PKR 874.86 PKR 62.49/tablet 99% above median
Am-Descol Amlodipine + Atorvastatin 10 mg + 20 mg Tablet 10's 047164 PKR 624.89 PKR 62.49/tablet 99% above median
Am-Descol Amlodipine + Atorvastatin 10 mg + 40 mg Tablet 14's 047165 PKR 1,335.30 PKR 95.38/tablet Near median
Am-Descol Amlodipine + Atorvastatin 10 mg + 40 mg Tablet 10's 047165 PKR 953.79 PKR 95.38/tablet Near median
Amdipine Amlodipine 2.5 mg Tablet 20's 029754 PKR 110.12 PKR 5.51/tablet Near median
Amdipine Amlodipine 5 mg Tablet 20's 029755 PKR 216.86 PKR 10.84/tablet Near median
Amdipine Amlodipine 10 mg Tablet 20's 029756 PKR 326.33 PKR 16.32/tablet 8% below median
Ampril Amlodipine + Lisinopril 5 mg + 10 mg Tablet 10's 086872 PKR 248.51 PKR 24.85/tablet No comparator
Asap Acetylsalicylic acid (Aspirin) 150 mg Tablet 30's 101258 PKR 68.10 PKR 2.27/tablet 10% below median
Asap Acetylsalicylic acid (Aspirin) 75 mg Tablet 30's 101259 PKR 48.64 PKR 1.62/tablet 21% below median
ASAP Acetylsalicylic acid (Aspirin) 300 mg Tablet 30's 114563 PKR 125.84 PKR 4.19/tablet 26% above median
Asco-C Ascorbic acid 100 mg Tablet 1000's 044012 PKR 552.38 PKR 0.55/tablet 124% above median
Asco-C Ascorbic acid 500 mg Tablet 40’s 104457 PKR 55.00 PKR 1.38/tablet 5% below median
Avirlo Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 104456 PKR 13,254.00 PKR 110.45/tablet 15% above median
Avirlo Lopinavir + Ritonavir 100 mg + 25 mg Tablet 120's 112507 PKR 8,957.74 PKR 74.65/tablet Near median
Bacip Ciprofloxacin 500 mg Tablet 10's 055591 PKR 444.05 PKR 44.41/tablet Near median
Bacip Ciprofloxacin 250 mg Tablet 10's 076040 PKR 268.50 PKR 26.85/tablet 6% above median
Bacip Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 105162 PKR 276.13 PKR 4.60/mL 9% below median
Baxim Cefotaxime 250 mg Injection 1's 027201 PKR 110.89 PKR 110.89/vial/unit 5% above median
Baxim Cefotaxime 500 mg Injection 1's 027202 PKR 167.12 PKR 167.12/vial/unit Near median
Baxim Cefotaxime 1 g Injection 1's 027203 PKR 300.57 PKR 300.57/vial/unit Near median
Bepsar Losartan 50 mg Tablet 20's 027206 PKR 720.00 PKR 36.00/tablet 73% above median
Bepsar Losartan 25 mg Tablet 20's 033384 PKR 235.15 PKR 11.76/tablet Near median
Bepsar Losartan + Hydrochlorothiazide 50 mg + 12.5 mg Tablet 20's 034471 PKR 628.16 PKR 31.41/tablet Near median
Bioplex Thiamine + Pyridoxine + Riboflavin + Nicotinamide 3 mg + 2 mg + 2 mg + 20 mg Tablet 1000's 042481 PKR 120.08 PKR 0.12/tablet No comparator
Buzon Risperidone 1 mg Tablet 20's 029004 PKR 485.76 PKR 24.29/tablet Near median
Buzon Risperidone 1 mg Tablet 10's 029004 PKR 247.84 PKR 24.78/tablet 6% above median
Buzon Risperidone 2 mg Tablet 20's 029005 PKR 971.54 PKR 48.58/tablet 32% above median
Buzon Risperidone 2 mg Tablet 10's 029005 PKR 495.69 PKR 49.57/tablet 35% above median
Buzon Risperidone 3 mg Tablet 10's 029006 PKR 702.22 PKR 70.22/tablet 21% above median
Buzon Risperidone 4 mg Tablet 10's 029007 PKR 945.92 PKR 94.59/tablet 31% above median
Calcovorin Calcium folinate (folinic acid) 50 mg Injection 1’s 108622 PKR 649.26 PKR 649.26/vial/unit No comparator
Carpro Carvedilol 25 mg Tablet 10's 039405 PKR 423.64 PKR 42.36/tablet 27% above median
Carpro Carvedilol 6.25 mg Tablet 30's 039707 PKR 338.91 PKR 11.30/tablet 12% above median
Carpro Carvedilol 12.5 mg Tablet 30's 039708 PKR 381.27 PKR 12.71/tablet 14% below median
Carpro Carvedilol 3.125 mg Tablet 10's 061662 PKR 169.45 PKR 16.95/tablet Near median
Cefexol Cefixime 100 mg/5 mL Suspension 30 ml 025641 PKR 330.39 PKR 11.01/mL Near median
Cefexol Cefixime 400 mg Capsule 5's 025642 PKR 592.03 PKR 118.41/capsule Near median
Cefexol Cefixime 200 mg Capsule 5's 110422 PKR 275.47 PKR 55.09/capsule 12% below median
Cefexol DS Cefixime 200 mg/5 mL Suspension 30 ml 034464 PKR 404.31 PKR 13.48/mL Near median
Clarithro Clarithromycin 250 mg Tablet 10's 025908 PKR 571.18 PKR 57.12/tablet 20% above median
Clarithro Clarithromycin 500 mg Tablet 10's 025909 PKR 1,107.22 PKR 110.72/tablet 33% above median
Clarithro Clarithromycin 125 mg/5 mL Suspension 60ml 025910 PKR 458.05 PKR 7.63/mL Near median
Clarithro Clarithromycin 125 mg/5 mL Suspension 30ml 025910 PKR 214.79 PKR 7.16/mL Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Nabiqasim Industries (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/nabiqasim-industries-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.